Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IJ0U
|
|||
| Former ID |
DNCL003772
|
|||
| Drug Name |
TS-071
|
|||
| Synonyms |
Luseogliflozin; 898537-18-3; UNII-C596HWF74Z; C596HWF74Z; CHEMBL1093423; Luseogliflozin [INN]; TS-071; TS-71; TS 071; Tube105; ts71; SCHEMBL1487519; DTXSID10237921; CHEBI:134725; ZINC49087932; BDBM50315426; AKOS027326750; SB11169; DB12214; (1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol; D-Glucitol, 1,5-dideoxy-1,5-epithio-1-C-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-, (1S); D-Glucitol, 1,5-dideoxy-1,5-epithio-1-C-(5-((4-ethoxyphenyl)methyl)-2-methoxy-4-methylphenyl)-, (1S)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | NDA filed | [1] | |
| Company |
Taisho Pharmaceutical
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H30O6S
|
|||
| Canonical SMILES |
CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2C)OC)C3C(C(C(C(S3)CO)O)O)O
|
|||
| InChI |
1S/C23H30O6S/c1-4-29-16-7-5-14(6-8-16)10-15-11-17(18(28-3)9-13(15)2)23-22(27)21(26)20(25)19(12-24)30-23/h5-9,11,19-27H,4,10,12H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1
|
|||
| InChIKey |
WHSOLWOTCHFFBK-ZQGJOIPISA-N
|
|||
| CAS Number |
CAS 898537-18-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:134725
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Taisho Pharmaceutical. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.